Anaplan, Inc. Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q1 FY2023 As of Apr 30, 2022	Q4 FY2022 As of Jan 31, 2022	Q3 FY2022 As of Oct 31, 2021	Q2 FY2022 As of Jul 31, 2021	Q1 FY2022 As of Apr 30, 2021	Q4 FY2021 As of Jan 31, 2021	Q3 FY2021 As of Oct 31, 2020	Q2 FY2021 As of Jul 31, 2020	Q1 FY2021 As of Apr 30, 2020	Q4 FY2020 As of Jan 31, 2020	Q3 FY2020 As of Oct 31, 2019	Q2 FY2020 As of Jul 31, 2019	Q1 FY2020 As of Apr 30, 2019	Q4 FY2019 As of Jan 31, 2019	Q3 FY2019 As of Oct 31, 2018
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net of allowances for credit losses of $3,090 and $3,224 as of April 30, 2022 and January 31, 2022, respectively
Deferred commissions, current portion
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Deferred commissions, net of current portion
Goodwill
Intangible assets, net
Operating lease right-of-use assets
Other noncurrent assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
Accrued expenses
Deferred revenue, current portion
Operating lease liabilities, current portion
Total current liabilities
Deferred revenue, net of current portion
Operating lease liabilities, net of current portion
Other noncurrent liabilities
TOTAL LIABILITIES
Stockholders' equity:
Common stock, par value of $0.0001 per share; 1,750,000 shares authorized as of April 30, 2022 and January 31, 2022; 150,483 and 149,089 shares issued and outstanding as of April 30, 2022 and January 31, 2022
Accumulated other comprehensive loss
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

Comments